• Exclusive invites to Tea Ceremonies and behind-the-scenes farm tours just for members.
• Choose from Milagro Mushrooms, Cactus Powder, or a delightful blend of both for your monthly share.
• Early and special access to captivating Milagro Mushroom content and insightful interviews.
• Exclusive discounts on upcoming enlightening workshops.
• Special savings on Frangiosa Farms' renowned Mushroom & Botanical Honeys and Colorado Hemp Honey CBD products.

To be eligible for a Milagro Mushroom membership, all potential members must adhere to the following criteria:

• Residency: Applicants must have established legal residency in a regulated state or jurisdiction. Proof of residency, such as a valid driver's license or utility bill, may be requested during the application process or at any time thereafter.

• Age Limit: All applicants should be 21 years of age or older. A valid government-issued ID will be required to verify age.

• Subscription Fee: Members must commit to an automatic monthly subscription fee, which ranges between $40 and $102, depending on the chosen subscription tier. This fee will be charged recurrently each month to the provided payment method.

Established in 2023, Milagro Mushrooms proudly stands as Colorado's pioneer in the Psilocybin and Mescaline farm share program. Nestled on a sprawling 10-acre farm, we also boast a state-of-the-art 5,000 sq ft facility, out of which 2,500 sq ft is dedicated to production and administrative operations.

Our dedication to quality is unwavering. Every batch of our psilocybin-rich mushrooms undergoes rigorous potency testing, with results transparently displayed on our website. Moreover, we undertake supplementary tests when deemed necessary, ensuring our products meet the highest purity standards for safe consumption.

Our detailed test results aren't merely numerical data; they're a testament to our commitment. They serve as a qualitative guide, reinforcing your confidence in the authenticity and potency of our offerings.

01 Psilocybin Batch Lab Results - Certificate of Analysis

This is an ever changing landscape.  At the moment, several states and jurisdictions have initiated or considered measures to regulate and decriminalize certain plant medicines, including psychedelic mushrooms.

However, laws can change, and it's crucial to verify the current legal status in specific locations. 

Some areas with more progressive stances on plant medicines include:

• Colorado: Denver and the state of Colorado have decriminalized psilocybin mushrooms for personal use.
• Oregon: Oregon has passed a measure allowing for the regulated medical use of psilocybin.
• California: Several cities, including Oakland and Santa Cruz, have decriminalized the use of natural psychedelics.
• Washington, D.C.: Voters in Washington, D.C., approved a ballot initiative decriminalizing the use of psychedelic plants.
• Massachusetts: Some cities, including Cambridge and Somerville, have decriminalized natural psychedelics.

It's important to note that the legal landscape is evolving, and additional states may be exploring or enacting similar measures.

Always check the most recent and relevant legal information, as changes may occur after my last update.

Additionally, while decriminalization is occurring in some places, the medical or therapeutic use of these substances is often more limited and subject to specific regulations.

With the recent passing of Proposition 122, Colorado introduces the groundbreaking Natural Medicine Health Act. This act decriminalizes the use of psilocybin and psilocin, the psychedelic compounds in specific mushroom strains, for individuals aged 21 and over. Moreover, substances like DMT, ibogaine, and mescaline are now supported under this act, with the exception of peyote.

What's the implication for you? You now have a legal avenue to tap into the profound natural healing properties that our ancestors embraced over 6,000 years ago. Please note, Milagro Memberships will be exclusively available to Colorado residents aged 21 and above, determined through a thorough review process.

Colorado has recently ratified Proposition 122, which brings a paradigm shift in how the state views certain psychedelics.

In essence, Proposition 122 allows for:

• The decriminalization of personal possession, cultivation, sharing, and consumption (excluding sale) of specific natural psychedelic substances for those aged 21 and over. This list includes psilocybin and psilocin from psychedelic mushrooms and the plant-derived substances dimethyltryptamine, ibogaine, and mescaline.
• By the end of 2024, provisions will be in place to permit supervised consumption of psychedelic mushrooms at regulated establishments for individuals over 21. Additionally, the state is expected to implement a comprehensive regulatory framework for these establishments.
• Starting in 2026, the state may further extend the range of substances permitted for use in licensed establishments to incorporate other plant-based psychedelics like DMT, ibogaine, and mescaline.
• Local governments are restricted from banning these licensed venues or the services they offer. However, they retain the authority to regulate the operational hours, locations, and modalities of these establishments.
• Penalties will be imposed on those under 21 found in possession, consumption, or transportation of these psychedelic substances. Adults aged 21 and over will face consequences if they provide underage individuals access to these substances.

A farm share, often referred to as a CSA (Community Supported Agriculture), is a unique arrangement where individuals pre-purchase a portion of a local farm's upcoming harvest before the crops are sown. Here's how it works:

Farmers earmark a predefined number of shares available for purchase at a predetermined price. As the growing season progresses, farms cultivate a range of fresh produce, which is then regularly distributed to shareholders—typically on a weekly basis. The assortment within each share fluctuates based on what crops are seasonally ripe and ready for harvest.

Engaging in a farm share not only ensures consumers have access to the freshest local produce but also actively backs grassroots agriculture and bolsters the community's food ecosystem. Additionally, it fosters a more intimate bond between consumers and the source of their food, bridging the gap between farm and table.

Micro-dosing psilocybin magic mushrooms has become increasingly popular in recent years as a way to potentially enhance mental and emotional wellbeing. Some people micro-dose for the reported benefits, which may include increased creativity, improved focus, and decreased anxiety and depression symptoms. Others use it as a tool for personal growth and self-exploration.

Research on the effects of micro-dosing psilocybin is still in its early stages, but preliminary studies and anecdotal evidence suggest that it may have potential therapeutic benefits. However, it's important to note that the use of psilocybin mushrooms should only be done under medical supervision and in accordance with local laws.

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms, commonly referred to as "magic mushrooms." When ingested, psilocybin is metabolized into psilocin, which is responsible for its psychedelic effects.

Psilocybin is classified as a Schedule I substance in the United States, meaning it is considered to have a high potential for abuse and no currently accepted medical use. However, recent research has shown promising results in the potential therapeutic uses of psilocybin, particularly in the treatment of depression, anxiety, and other mental health conditions.

Micro-dosing psilocybin, which involves taking small amounts of the psychedelic compound found in magic mushrooms, has been reported by some people to provide a range of potential benefits. While research on the effects of micro-dosing psilocybin is still in its early stages, some of the potential benefits reported by users and initial studies include: 

• Increased creativity: Some people report that micro-dosing psilocybin enhances their creativity, problem-solving abilities, and innovative thinking.
• Improved mood: Micro-dosing may have mood-boosting effects, potentially reducing symptoms of depression and anxiety and improving overall well-being.
• Increased focus and productivity: Micro-dosing may also improve focus and concentration, helping individuals become more productive and efficient in their daily tasks.
• Increased empathy and social connectedness: Micro-dosing may promote feelings of empathy and social connectedness, helping individuals better relate to others and build stronger relationships.

It's important to note that the potential benefits of micro-dosing psilocybin are still being studied, and it is not a substitute for medical or mental health treatment. Anyone considering micro-dosing psilocybin should consult with a qualified healthcare professional or shaman and carefully research the potential risks and benefits beforehand.

The Default Mode Network (DMN) is a network of interconnected brain regions that are active when an individual is not focused on the external environment, such as during daydreaming, mind wandering, or introspection. The DMN is often described as the "resting state" of the brain, as it is active when an individual is not engaged in a specific task or sensory input. 

The DMN is thought to be involved in various cognitive functions, including self-reflection, memory recall, social cognition, and moral reasoning. It has also been implicated in certain mental health disorders, such as depression, anxiety, and addiction. 

Research on the DMN is ongoing, and scientists continue to explore the network's complex functions and potential implications for understanding brain function and mental health.

There is growing interest in the potential of psilocybin-assisted therapy for treating post-traumatic stress disorder (PTSD), including among veterans. While research on this topic is still in its early stages, some studies have suggested that psilocybin may help individuals with PTSD by reducing symptoms such as anxiety, depression, and avoidance behaviors.

One study published in the Journal of Psychopharmacology in 2016 found that participants who received psilocybin-assisted therapy experienced significant reductions in symptoms of anxiety and depression related to their PTSD, and these effects persisted for up to 12 months following treatment. Another study published in the same journal in 2018 found that psilocybin-assisted therapy reduced symptoms of PTSD in 5 of 6 participants.

Some researchers suggest that the therapeutic benefits of psilocybin may be related to the compound's ability to promote neuroplasticity and enhance emotional processing. Additionally, psilocybin may help individuals with PTSD by increasing their sense of connection to others and their environment, reducing feelings of isolation and disconnection.

It's important to note that research on psilocybin-assisted therapy for PTSD is still in its early stages, and the treatment is not yet widely available or approved by regulatory agencies. Anyone considering this treatment should consult with a qualified healthcare professional or shaman and carefully consider the potential risks and benefits.

Mescaline is a naturally occurring psychedelic compound found in several species of cactus, most notably the peyote cactus (Lophophora williamsii) that is native to Mexico and parts of southwestern United States. It has been used for centuries by indigenous peoples in religious and spiritual ceremonies.

Mescaline is a phenethylamine compound and belongs to a class of drugs known as hallucinogens or psychedelics. It produces altered states of consciousness, including changes in perception, thought, and emotion. The effects of mescaline can last for several hours and may include visual and auditory hallucinations, feelings of euphoria, and altered sense of time and space.

Mescaline has been studied for its potential therapeutic uses, including for the treatment of alcoholism and anxiety. However, its use is illegal in many countries, including the United States, except in specific religious or spiritual contexts. It is also considered a Schedule I substance under the United Nations' Convention on Psychotropic Substances, meaning it has a high potential for abuse and no accepted medical use.

The use of niacin (vitamin B3) alongside psilocybin is a topic of debate among researchers and clinicians, and there is currently limited scientific evidence to support its use.

Some people believe that taking niacin alongside psilocybin may enhance the effects of the psychedelic experience, leading to deeper introspection and personal insight. Others claim that niacin can help alleviate potential negative side effects of psilocybin, such as anxiety and paranoia.

However, it's important to note that the potential benefits and risks of taking niacin with psilocybin are not yet fully understood, and there is little scientific evidence to support these claims. Additionally, the combination of niacin and psilocybin may have the potential to cause adverse reactions or negative side effects.

If you are considering taking niacin alongside psilocybin, it is important to consult with a qualified healthcare professional or shaman first to discuss the potential risks and benefits and determine whether this combination is safe for you.